ZEUS System (Zio Watch) vs Sleepiz One+

Sleepiz One+ offers contactless monitoring, which generally enhances patient comfort and reduces the burden associated with wearables. Its setup is described as quick and easy, taking less than 5 minutes, and it features automatic cellular data transmission, simplifying the user experience. In contrast, while the Zio Watch is a wearable, iRhythm has focused on making it lightweight, breathable, and waterproof for comfort and ease of use, and it includes a patient app for symptom logging and reminders.

The ZEUS System (Zio Watch) is specifically designed for long-term continuous cardiac monitoring to detect and characterize AFib and other cardiac arrhythmias, providing clinically actionable reports with a high physician agreement rate (99%). It leverages a vast repository of labeled ECG data and deep-learned AI algorithms, clinically proven to be as accurate as expert cardiologists. Sleepiz One+ offers contactless monitoring of respiration and heart rate, with clinical validation showing high accuracy against gold-standard methods for these vital signs and for sleep apnea detection in patients with moderate to severe OSA. However, the specialized and highly validated focus of ZEUS on cardiac arrhythmias, a critical and often asymptomatic condition, gives it a slight edge in clinical value for its target use case.

Both tools require contacting the vendor for specific pricing, indicating a lack of public transparency. Sleepiz One+ highlights that its use can be reimbursed using existing CPT codes for remote patient monitoring, allowing for 16 out of 30 days of measurements for billing purposes, which adds clear value for providers. The Zio Watch is described as a cost-effective, noninvasive monitoring solution, and iRhythm has programs to help patients understand insurance benefits. Without specific pricing details for either, it's difficult to definitively declare a winner, as both aim to provide value through improved patient management and potential cost savings.

iRhythm Technologies, with its Zio suite of products, has a more established presence in the cardiac monitoring industry, with over 8 million patients served and 1.5 billion hours of heartbeat data analyzed. Their system is cloud-based and integrates with a provider portal and mobile app for report interpretation and patient management, demonstrating a robust infrastructure for enterprise deployment. Sleepiz One+ also offers a web application for data access and analysis and is designed for easy setup and deployment in senior care environments, with HIPAA compliance and BAA in place. However, iRhythm's extensive experience and larger scale suggest a more mature enterprise readiness.

Both tools demonstrate significant innovation in their respective fields. The ZEUS System (Zio Watch) utilizes an FDA-cleared, deep-learned AI algorithm for advanced arrhythmia detection and analysis from continuous ECG and PPG data, building on a vast dataset. Sleepiz One+ stands out with its contactless radar technology for remote patient monitoring, measuring vital signs and screening for sleep apnea without physical contact, which is a novel approach to patient comfort and data collection. Both represent forward-thinking solutions in remote patient monitoring.

iRhythm Technologies provides comprehensive support through a dedicated customer care line, email support, and a patient app (MyZio) that offers FAQs, instructional videos, and symptom logging. They also offer detailed instructions for use (IFUs) for their devices and software. Sleepiz provides FAQs and contact information for support, and their setup instructions are designed to be straightforward. However, iRhythm's broader range of readily available patient and clinician resources, including extensive clinical evidence and a dedicated resource center, suggests a more robust support and documentation ecosystem.